BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 11713231)

  • 21. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental models of transcription factor-associated maturity-onset diabetes of the young.
    Wang H; Hagenfeldt-Johansson K; Otten LA; Gauthier BR; Herrera PL; Wollheim CB
    Diabetes; 2002 Dec; 51 Suppl 3():S333-42. PubMed ID: 12475772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
    Hattersley AT
    Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular background and clinical characteristics of autosomal dominant type 2 diabetes mellitus].
    Małecki M; Krolewski AS
    Przegl Lek; 2000; 57 Suppl 3():13-8. PubMed ID: 11293229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism.
    Shih DQ; Screenan S; Munoz KN; Philipson L; Pontoglio M; Yaniv M; Polonsky KS; Stoffel M
    Diabetes; 2001 Nov; 50(11):2472-80. PubMed ID: 11679424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.
    Bulman MP; Harries LW; Hansen T; Shepherd M; Kelly WF; Hattersley AT; Ellard S
    Diabetologia; 2002 Oct; 45(10):1463-7. PubMed ID: 12378390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MODY, a model of genotype/phenotype interactions in type 2 diabetes].
    Velho G; Bellanné-Chantelot C; Timsit J
    Med Sci (Paris); 2003; 19(8-9):854-9. PubMed ID: 14593617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization.
    Owen K; Hattersley AT
    Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):309-23. PubMed ID: 11554773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maturity-onset diabetes of the young (MODY), MODY genes and non-insulin-dependent diabetes mellitus.
    Velho G; Froguel P
    Diabetes Metab; 1997 Mar; 23 Suppl 2():34-7. PubMed ID: 9162575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young.
    Iwasaki N; Ogata M; Tomonaga O; Kuroki H; Kasahara T; Yano N; Iwamoto Y
    Diabetes Care; 1998 Dec; 21(12):2144-8. PubMed ID: 9839108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proposed mechanism for a novel insertion/deletion frameshift mutation (I414G415ATCG-->CCA) in the hepatocyte nuclear factor 1 alpha (HNF-1 alpha) gene which causes maturity-onset diabetes of the young (MODY).
    Ellard S; Bulman MP; Frayling TM; Shepherd M; Hattersley AT
    Hum Mutat; 2000 Sep; 16(3):273. PubMed ID: 10980542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3.
    Kim KA; Kang K; Chi YI; Chang I; Lee MK; Kim KW; Shoelson SE; Lee MS
    Diabetologia; 2003 May; 46(5):721-7. PubMed ID: 12712243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta.
    Shih DQ; Heimesaat M; Kuwajima S; Stein R; Wright CV; Stoffel M
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3818-23. PubMed ID: 11904435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families.
    Reznik Y; Dao T; Coutant R; Chiche L; Jeannot E; Clauin S; Rousselot P; Fabre M; Oberti F; Fatome A; Zucman-Rossi J; Bellanne-Chantelot C
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1476-80. PubMed ID: 15001650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies.
    Aguilera E; Casamitjana R; Ercilla G; Oriola J; Nicoletti F; Gomis R; Conget I
    Diabet Med; 2005 Feb; 22(2):137-43. PubMed ID: 15660729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
    Menzel R; Kaisaki PJ; Rjasanowski I; Heinke P; Kerner W; Menzel S
    Diabet Med; 1998 Oct; 15(10):816-20. PubMed ID: 9796880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization.
    Yoshiuchi I; Yamagata K; Yang Q; Iwahashi H; Okita K; Yamamoto K; Oue T; Imagawa A; Hamaguchi T; Yamasaki T; Horikawa Y; Satoh T; Nakajima H; Miyazaki J; Higashiyama S; Miyagawa J; Namba M; Hanafusa T; Matsuzawa Y
    Diabetologia; 1999 May; 42(5):621-6. PubMed ID: 10333057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a new mutation in the hepatocyte nuclear factor-1alpha gene in a Polish family with early-onset type 2 diabetes mellitus.
    Malecki MT; Klupa T; Frey J; Cyganek K; Galicka-Stankowska D; Wanic K; Sieradzki J
    Diabetes Nutr Metab; 2001 Oct; 14(5):288-91. PubMed ID: 11806470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profile of MODY3/HNF-1alpha protein in the developing mouse pancreas.
    Nammo T; Yamagata K; Hamaoka R; Zhu Q; Akiyama TE; Gonzalez FJ; Miyagawa J; Matsuzawa Y
    Diabetologia; 2002 Aug; 45(8):1142-53. PubMed ID: 12189445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
    Boileau P; Wolfrum C; Shih DQ; Yang TA; Wolkoff AW; Stoffel M
    Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.